Are randomised trials obsolete or more important than ever? - European Medical Journal

Are randomised trials obsolete or more important than ever?

Oncology
At the 14th St. Gallen International Breast Cancer Conference (SG-BCC) 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) discusses the use of electronic medical records as a source of data that could potentially transform healthcare. CancerLinQ is one initiative that is aiming to aggregate and analyse data collected from patients.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given